Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1608147

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1608147

Intraoperative Neuromonitoring Market by Type (Insource IONM, Outsource IONM), Modality (Brainstem Auditory Evoked Potentials, Electroencephalography, Electromyography), Application - Global Forecast 2025-2030

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (2-5 User License)
USD 4249
PDF, Excel & 1 Year Online Access (Site License)
USD 5759
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Intraoperative Neuromonitoring Market was valued at USD 3.13 billion in 2023, expected to reach USD 3.31 billion in 2024, and is projected to grow at a CAGR of 5.69%, to USD 4.62 billion by 2030.

Intraoperative neuromonitoring (IONM) is a specialized procedure used during surgeries to monitor the neural pathways in real-time, reducing the risk of nerve or spinal cord damage. The necessity of IONM stems from its ability to provide immediate feedback to surgeons, enhancing patient safety, particularly during complex surgeries involving the brain, spine, and nerves. Its applications are broad, spanning orthopedic, neurosurgical, vascular, and ENT procedures. The end-use scope includes hospitals, surgical centers, and specialty clinics, where demand is driven by the increasing volume of surgeries and the desire to minimize surgical complications.

KEY MARKET STATISTICS
Base Year [2023] USD 3.13 billion
Estimated Year [2024] USD 3.31 billion
Forecast Year [2030] USD 4.62 billion
CAGR (%) 5.69%

Market insights reveal several key factors influencing growth, including technological advancements, an aging population requiring more surgeries, and increasing awareness among healthcare professionals about patient safety benefits. Opportunities abound in emerging markets, where healthcare infrastructure is expanding, and in the integration of artificial intelligence and machine learning to enhance monitoring accuracy and predictive analytics. To seize these opportunities, companies should focus on expanding their presence in these regions and investing in R&D for more sophisticated, user-friendly devices.

Challenges impeding market growth include high equipment costs, a shortage of skilled professionals to operate IONM technologies, and complex regulatory hurdles. Furthermore, the rapid pace of technological change demands constant adaptation by healthcare providers, which can be a barrier for widespread adoption.

Innovation should concentrate on developing cost-effective solutions and enhancing wireless connectivity and interoperability with other surgical systems. Research into non-invasive monitoring techniques could offer new avenues for business growth. The nature of the IONM market is dynamic, characterized by continuous technological innovations and a competitive landscape. Businesses should prioritize strategic partnerships, continuous technological updates, and comprehensive training programs for healthcare professionals to maintain a competitive edge. By being proactive in addressing these challenges and leveraging new technologies, businesses can drive growth and establish a strong market presence.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intraoperative Neuromonitoring Market

The Intraoperative Neuromonitoring Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of various lifestyles associated chronic diseases
    • Favorable reimbursement policies and demand for safer surgery practices
    • Rising trend of outsourcing Intraoperative Neuromonitoring
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Technological advancements in neuromonitoring to minimize the risks during surgery
    • Increased R&D investments by governmental bodies
  • Market Challenges
    • Dearth of skilled professionals and low awareness

Porter's Five Forces: A Strategic Tool for Navigating the Intraoperative Neuromonitoring Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intraoperative Neuromonitoring Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intraoperative Neuromonitoring Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intraoperative Neuromonitoring Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intraoperative Neuromonitoring Market

A detailed market share analysis in the Intraoperative Neuromonitoring Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intraoperative Neuromonitoring Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intraoperative Neuromonitoring Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intraoperative Neuromonitoring Market

A strategic analysis of the Intraoperative Neuromonitoring Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intraoperative Neuromonitoring Market, highlighting leading vendors and their innovative profiles. These include Accurate Monitoring, LLC, Argos Neuromonitoring LP, Biotronic NeuroNetwork, LLC, Cadwell Industries, Inc., Computational Diagnostics, Inc., Emotiv Inc., inomed Medizintechnik GmbH, Intranerve, LLC, Medsurant Health, Medtronic PLC, Moberg Research Inc., Natus Medical Incorporated, NeuroMonitoring Technologies, NeuroSentinel LLC, Nihon Kohden Corporation, NuVasive Inc, Procirca, ProPep Surgical, and SpecialtyCare, Inc..

Market Segmentation & Coverage

This research report categorizes the Intraoperative Neuromonitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Insource IONM and Outsource IONM.
  • Based on Modality, market is studied across Brainstem Auditory Evoked Potentials, Electroencephalography, Electromyography, Motor Evoked Potentials, Somatosensory Evoked Potentials, and Visual Evoked Potentials.
  • Based on Application, market is studied across ENT Surgery, Neurosurgery, Orthopedic Surgery, Spinal Surgery, and Vascular Surgery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-AD36CD8980BB

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of various lifestyles associated chronic diseases
      • 5.1.1.2. Favorable reimbursement policies and demand for safer surgery practices
      • 5.1.1.3. Rising trend of outsourcing Intraoperative Neuromonitoring
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in neuromonitoring to minimize the risks during surgery
      • 5.1.3.2. Increased R&D investments by governmental bodies
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals and low awareness
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intraoperative Neuromonitoring Market, by Type

  • 6.1. Introduction
  • 6.2. Insource IONM
  • 6.3. Outsource IONM

7. Intraoperative Neuromonitoring Market, by Modality

  • 7.1. Introduction
  • 7.2. Brainstem Auditory Evoked Potentials
  • 7.3. Electroencephalography
  • 7.4. Electromyography
  • 7.5. Motor Evoked Potentials
  • 7.6. Somatosensory Evoked Potentials
  • 7.7. Visual Evoked Potentials

8. Intraoperative Neuromonitoring Market, by Application

  • 8.1. Introduction
  • 8.2. ENT Surgery
  • 8.3. Neurosurgery
  • 8.4. Orthopedic Surgery
  • 8.5. Spinal Surgery
  • 8.6. Vascular Surgery

9. Americas Intraoperative Neuromonitoring Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intraoperative Neuromonitoring Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intraoperative Neuromonitoring Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accurate Monitoring, LLC
  • 2. Argos Neuromonitoring LP
  • 3. Biotronic NeuroNetwork, LLC
  • 4. Cadwell Industries, Inc.
  • 5. Computational Diagnostics, Inc.
  • 6. Emotiv Inc.
  • 7. inomed Medizintechnik GmbH
  • 8. Intranerve, LLC
  • 9. Medsurant Health
  • 10. Medtronic PLC
  • 11. Moberg Research Inc.
  • 12. Natus Medical Incorporated
  • 13. NeuroMonitoring Technologies
  • 14. NeuroSentinel LLC
  • 15. Nihon Kohden Corporation
  • 16. NuVasive Inc
  • 17. Procirca
  • 18. ProPep Surgical
  • 19. SpecialtyCare, Inc.
Product Code: MRR-AD36CD8980BB

LIST OF FIGURES

  • FIGURE 1. INTRAOPERATIVE NEUROMONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTRAOPERATIVE NEUROMONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTRAOPERATIVE NEUROMONITORING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAOPERATIVE NEUROMONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAOPERATIVE NEUROMONITORING MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY INSOURCE IONM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY OUTSOURCE IONM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY BRAINSTEM AUDITORY EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ELECTROMYOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MOTOR EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY SOMATOSENSORY EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY VISUAL EVOKED POTENTIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ENT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY VASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. INTRAOPERATIVE NEUROMONITORING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. INTRAOPERATIVE NEUROMONITORING MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!